NCT01481142 - Adacolumn in Refractory UC Patients Trial | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2015

Conditions

Ulcerative Colitis, Active Moderate

Interventions

DEVICE

(GMA) Adsorptive Apheresis

Patients will be treated with once-weekly Adacolumn® apheresis over 5 consecutive weeks; treatment can be extended to up to 10 treatments administered once weekly over 10 weeks.

Trial Locations (1)

38 043

Clinique Universitaire d'Hépato-Gastroentérologie, Grenoble